Target intelligence / Profile preview

Bacterial flavoenzyme

Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Bacterial flavoenzymes are a diverse group of proteins that utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as essential cofactors to catalyze a wide range of redox reactions (Joosten & van Berkel, 2007, https://doi.org/10.1016/j.cbpa.2007.01.010). These enzymes play critical roles in bacterial metabolism, including the respiratory chain, fatty acid oxidation, and the biosynthesis of essential nutrients (Massey, 2000, https://doi.org/10.1042/bst0280283). In the context of pharmacology, they are significant because several clinical antibiotics, such as nitrofurantoin and metronidazole, act as prodrugs that are specifically activated by bacterial flavoenzymes, such as oxygen-insensitive nitroreductases, into toxic reactive species that damage bacterial DNA and proteins (Williams et al., 2015, https://doi.org/10.1099/mic.0.000011). Furthermore, because certain bacterial flavoenzymes have unique structural features or metabolic roles not found in humans, they are being actively explored as targets for novel narrow-spectrum antimicrobial agents (Macheroux et al., 2011, https://doi.org/10.1111/j.1742-4658.2011.08060.x). However, the high degree of conservation in some flavin-binding sites poses a challenge for achieving selectivity over human mitochondrial flavoenzymes (Walsh & Wencewicz, 2016, Antibiotics: Challenges, Mechanisms, Opportunities).

Other names
Bacterial flavoproteinFMN-dependent enzymeFAD-dependent enzymeFlavin-containing enzymeBacterial nitroreductase
02

Mechanism of action

Reductive bioactivation of prodrugs into reactive radicals; Competitive inhibition of flavin cofactor binding; Covalent modification of the flavin prosthetic group.

03

Biological functions

Redox catalysisElectron transportMetabolismDNA repairSignal transduction
04

Disease associations

Infection
05

Safety considerations

Cross-reactivity with human mitochondrial flavoenzymesDevelopment of antimicrobial resistance via loss-of-function mutationsInduction of oxidative stress in host cellsPotential mutagenicity of reactive intermediates
06

Interacting drugs

Nitrofurantoin

5 more in the full profile.

07

Biomarkers

nfsA gene expressionnfsB gene expressionBacterial redox potentialFlavin adenine dinucleotide levels

Beyond the preview

Go deeper on Bacterial flavoenzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial flavoenzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call